| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/26/2011 | CA2333162C Process for producing composite preparation containing nucleic acid |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011088209A2 1-deoxy analogs of vitamin d-related compounds |
| 07/21/2011 | WO2011088045A1 Aurora kinase compounds and methods of their use |
| 07/21/2011 | WO2011087823A1 Aldehydes for in vivo imaging of aldh in cancer stem cells |
| 07/21/2011 | WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011086541A1 Novel polymorph of nilotinib monohydrochloride monohydrate |
| 07/21/2011 | WO2011086424A1 Pharmaceutical use of multicyclic compounds mixtures as concomitant anti-cancer, anti-inflammatory and anti-pain agents |
| 07/21/2011 | WO2011086178A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7 |
| 07/21/2011 | WO2011086143A2 Liver targeting molecules |
| 07/21/2011 | WO2011086085A1 Thiazole and oxazole kinase inhibitors |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011085720A1 Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof |
| 07/21/2011 | WO2011085701A1 Stable protein kinase activators, preparation methods and uses thereof |
| 07/21/2011 | WO2011085641A1 Certain chemical entities, compositions, and methods |
| 07/21/2011 | WO2011085640A1 Colchiceinamide hydrates, preparation methods thereof, and uses thereof |
| 07/21/2011 | WO2011085544A1 Compounds which effecttively remove tumor or cancer cell |
| 07/21/2011 | WO2011085523A1 18-member or 14-member macrolides epothilone compounds and use thereof |
| 07/21/2011 | WO2011085473A1 Treating cancer with statins and compounds having dipyridamole activity |
| 07/21/2011 | WO2011034919A3 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer |
| 07/21/2011 | WO2011032169A3 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 07/21/2011 | WO2011031884A3 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/21/2011 | WO2011031503A3 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
| 07/21/2011 | WO2011028860A3 Compounds and compositions for treating cancer |
| 07/21/2011 | WO2011011384A9 Synthesis of dendrimer conjugates |
| 07/21/2011 | WO2011009987A3 Aureolic acid derivatives, the method for preparation thereof and the uses thereof |
| 07/21/2011 | WO2011000811A4 Pharmaceutical solutions for infusion |
| 07/21/2011 | WO2010121212A3 Indoline scaffold shp-2 inhibitors and method of treating cancer |
| 07/21/2011 | WO2010121153A3 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites |
| 07/21/2011 | WO2010091808A8 Fused pyrimidines |
| 07/21/2011 | WO2010071783A8 Thiazoles as cannabinoid receptor ligands |
| 07/21/2011 | US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B |
| 07/21/2011 | US20110178470 Pharmaceutical compositions comprising boronic acid compounds |
| 07/21/2011 | US20110178277 Stabilized single domain antibodies |
| 07/21/2011 | US20110178171 Compounds for cancer therapy |
| 07/21/2011 | US20110178170 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 07/21/2011 | US20110178163 Mir-182 in the diagnosis and treatment of cancer |
| 07/21/2011 | US20110178162 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110178161 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 07/21/2011 | US20110178159 Inhibitory rnas that regulate hematopoietic cells |
| 07/21/2011 | US20110178158 Set of Antiangiogenic Molecules and Use Thereof |
| 07/21/2011 | US20110178156 Method of suppressing pRb deficiency-induced tumor formation |
| 07/21/2011 | US20110178155 Silencing of csn5 gene expression using interfering rna |
| 07/21/2011 | US20110178154 gene expression profile that predicts ovarian cancer subject response to chemotherapy |
| 07/21/2011 | US20110178153 Methods of treating chemoresistance and relapse in cancer cells |
| 07/21/2011 | US20110178146 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/21/2011 | US20110178136 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178126 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 07/21/2011 | US20110178124 Pyridinium and quinolinium derivatives |
| 07/21/2011 | US20110178116 Methods of stimulating immune response in certain individuals |
| 07/21/2011 | US20110178112 PPAR Modulators |
| 07/21/2011 | US20110178110 Genotype and Expression Analysis for Use in Predicting Outcome and Therapy Selection |
| 07/21/2011 | US20110178106 5-quinolinone and imidazopyridine compounds and use thereof |
| 07/21/2011 | US20110178099 Pharmaceutical combination |
| 07/21/2011 | US20110178098 Anticancer compounds and methods of making and using same |
| 07/21/2011 | US20110178097 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178095 Tyrosine kinase inhibitors containing a zinc binding moiety |
| 07/21/2011 | US20110178093 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 07/21/2011 | US20110178087 Compositions and Their Use as Anti-Tumor Agents |
| 07/21/2011 | US20110178085 Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178076 Medical intervention in haematological cancers |
| 07/21/2011 | US20110178070 PI3K/mTOR INHIBITORS |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178066 Hydroxypiperidine derivatives and uses thereof |
| 07/21/2011 | US20110178065 Novel cyp17 inhibitors |
| 07/21/2011 | US20110178053 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 07/21/2011 | US20110178052 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 07/21/2011 | US20110178046 Methods for Treating Glioblastoma |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178040 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 07/21/2011 | US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 07/21/2011 | US20110178027 Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents |
| 07/21/2011 | US20110178026 Ricin-like toxins for treatment of cancer |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177179 Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology |
| 07/21/2011 | US20110177178 Extracts of Deschampsia antarctica Desv. with antineoplastic activity |
| 07/21/2011 | US20110177161 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177159 Custom-formulated phospholipid microbubbles and methods and uses thereof |
| 07/21/2011 | US20110177153 targeted nanoparticle drug for magnetic hyperthermia treatment on malignant tumors |
| 07/21/2011 | US20110177150 Implantable tissue compositions and method |
| 07/21/2011 | US20110177129 Methods and Compositions Using Peroxiredoxin 1 (PRX1) as an Adjuvant |
| 07/21/2011 | US20110177120 Mycobacterium tuberculosis vaccine |
| 07/21/2011 | US20110177113 Use of antrodia camphorata for treating diseases |
| 07/21/2011 | US20110177108 Lipid compounds for supression of tumorigenesis |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177104 Method for selective depletion of cd137 positive cells using anti-cd137 antibody-toxin complex |
| 07/21/2011 | US20110177103 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2011 | US20110177102 Targeted double stranded rna mediated cell killing |
| 07/21/2011 | US20110177101 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177100 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |